Skip to main content

Peer Review reports

From: Transgelin-2, a novel cancer stem cell-related biomarker, is a diagnostic and therapeutic target for biliary tract cancer

Original Submission
10 Jun 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
12 Aug 2023 Reviewed Reviewer Report - Lu Wang
22 Aug 2023 Reviewed Reviewer Report - Ranjit Mehta
9 Feb 2024 Author responded Author comments - Dawoon E. Jung
Resubmission - Version 3
9 Feb 2024 Submitted Manuscript version 3
15 Feb 2024 Author responded Author comments - Dawoon E. Jung
Resubmission - Version 4
15 Feb 2024 Submitted Manuscript version 4
16 Feb 2024 Author responded Author comments - Dawoon E. Jung
Resubmission - Version 5
16 Feb 2024 Submitted Manuscript version 5
19 Feb 2024 Author responded Author comments - Dawoon E. Jung
Resubmission - Version 6
19 Feb 2024 Submitted Manuscript version 6
20 Feb 2024 Author responded Author comments - Dawoon E. Jung
Resubmission - Version 7
20 Feb 2024 Submitted Manuscript version 7
22 Feb 2024 Reviewed Reviewer Report - Ranjit Mehta
1 Mar 2024 Reviewed Reviewer Report - Lu Wang
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
4 Mar 2024 Editorially accepted
20 Mar 2024 Article published 10.1186/s12885-024-12082-3

You can find further information about peer review here.

Back to article page